Follicular Lymphoma New Reference: SubQ Rituximab for Follicular Lymphoma Ulas D. Bayraktar, MD 2023-05-20
Uterine Cancer New Protocol: Pembrolizumab with Chemotherapy in Advanced Endometrial Cancer Ulas D. Bayraktar, MD 2023-04-14
Bladder Cancer New Protocol: Enfortumab Vedotin and Pembrolizumab in Advanced Urothelial Cancer Ulas D. Bayraktar, MD 2023-04-14
Head and Neck Cancer New Indication: Axitinib and Avelumab for Adenoid Cystic Carcinoma Ulas D. Bayraktar, MD 2023-04-14
Uterine Cancer New Indication: Trastuzumab Deruxtecan for her2-Expressing Advanced Uterine Cancer Ulas D. Bayraktar, MD 2023-04-14
Colorectal Cancer New Protocol: Tucatinib and Trastuzumab for Metastatic Colorectal Cancer Ulas D. Bayraktar, MD 2023-03-15
Bladder Cancer New Reference: Neoadjuvant CISplatin and Gemcitabine for Urothelial Cancer Ulas D. Bayraktar, MD 2023-03-15
Breast Cancer New Indication: Sacituzumab Govitecan for HR+, her2 Negative Breast Cancer Ulas D. Bayraktar, MD 2023-03-15
